Innovation

21 patent families (12 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 6,951 times.

Year	Filings
2014	4
2015	8
2016	13
2017	13
2018	13
2019	14
2020	4
2021	2
2022	2
2023	2
2025	2

Investor mix

22 investors on record; lead investors include Frazier Healthcare Partners, Qiming; 5 have since exited.

Investor type	Count	Share
Venture capital	12	55%
Private equity	6	27%
Other / undisclosed	4	18%